The analysis included 93 biotechs listed on the IPO trackers managed by BioPharma Dive and Endpoints News as of December 6. WebCaroline Lembck is a distinguished executive in the biotechnology and finance industries, recognized for her remarkable achievements. Healthtech and biotech has consistently been a top sector for the destination of venture capital in recent years. Largest investment: 12.1 million shares of Instil Bio worth $244 million at the time of its IPO, Total holding value of 2021 IPOs: $425.7 million. The biotech market has set a record for the number of initial public offerings in 2021. Abogen Biosciences Co., Ltd. Headquarters: Suzhou Abogen Biosciences makes it on this list by virtue of an impressive $700 million Series C round that it bagged in August 2021 one of the biggest-ever private biotech funding rounds. While waning public investor sentiment made the year a minor disaster for listed companies, closely held groups enjoyed their most successful 12 months ever, with secured venture capital eclipsing 2020s then record-breaking total by 26%. The business focuses on disruptive and clinically significant technologies with a long tradition of curative Biopharma investments and a recent focus on expanding digital health investments. CEO: John Doerr (chairman), Brook Byers (founder). It features some jaw Also includes one tools & services company, Rapid Micro Biosystems, which focuses on detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. See: http://fortune.com/2014/10/02/exclusive-atlas-venture-is-splitting-up/ The Indian startup/ VC ecosystem will truly come of age This information is up to date through 2009 - an incredibly difficult year for bio-tech companies to raise venture capital funding, as the financial crisis caused investing firms to become more cautious with their money, but many companies manage to attract VC investments in even in the toughest economic conditions. Founded in 2017, Active Capital is a venture capital firm based in San Antonio, Texas. Polaris Partners became the latest VC firm in the money on November 24, when it announced it had closed on its $450 million seventh fund, to be focused on healthcare and technology investments. htmlbody height HTML body div It is focused on investment opportunities in high-potential companies. The firm is headquartered in San Francisco, California. When Third Rock Ventures was established in 2007, the prospect of turning scientific advancements into ground-breaking medications set public imaginations on fire. 9 See announcement on the firms blog, http://indexventures.com/news-room/blog/our-new-fund-for-building-iconic-businesses Media, Services (Non-Financial), Software, Accelerator/Incubator, Early Stage VC, Later Stage VC, Seed Round, President Gordon Daugherty, CEO Joshua Baer. Apparel and Accessories, Beverages, Consumer Durables, Food Products, Healthcare, Other Restaurants, Hotels and Leisure, Services (Non-Financial), Software, Co-founders and General Partners Genevieve Gilbreath and Dan Graham. Exclusive analysis of biotech, pharma, and the life sciences, https://reports.statnews.com/products/2021-ranking-biotechs-top-venture-capital-firms?utm_source=statnews.com&utm_medium=referral&utm_campaign=stat_reports_articlewidget2.0&utm_content=0621sub-header1, Reporting from the frontiers of health and medicine, You've been selected! This venture capital firm was founded in 1977 with only $16 million in funding. 6. Founded in 2014, ATX Venture Partners is a US-based venture capital firm that focuses on seed, series A and early-stage B2B software investments, usually with a Texas-centric geographic focus. VC activity in biotechs grew by 45 percent in a year, taking the 2020 global total to $36.6 billion. The largest deal of 2021 was the transaction of Treeline Biosciences (USD 735m), while the most active investor was Alexandria Venture Investments with 51 investments in 2021. The firm primarily prefers to invest in the information technology sectors. RA Capital, an investor based in Boston, raised an $880 million fund in October, all of which is set to go toward healthcare and life-science companies. Insights about top trending companies, startups, investments and M&A activities, notable investors of these companies, their management team, and recent This was swiftly followed by another $300 million investment round in November 2021. Bill Wood Ventures is a venture capital firm based in Austin, Texas. The firm seeks to make investments in companies operating in business software, consumer internet, cloud service, enterprise software and other technology sectors. Perceptive Advisors, a hedge fund based in New York, has historically focused on public-company investing but has transitioned to investing in private companies in the past couple of years, particularly through its incubator Xontogeny. The capital total is a staggering 46% increase from its last set of funds, closed in May 2021 at $1.3 billion. The firm prefers to invest in companies from the software, blockchain, robotics, software-as-a-service, artificial intelligence, and machine learning sectors. One of the key Added to this, a new administration in the United States and its policy proposals, taxes, immigration, trade policy, and other issues that directly affect both VC investors and companies will all be on the table next year, PitchBook said in its 2021 U.S. venture capital outlook report. Despite the venture boom, fundraising by new niche VCs in America has fallen from a peak of $14bn in 2018 to an expected $5.5bn in 2021. See: http://www.sec.gov/Archives/edgar/data/1611731/000161173114000001/xslFormDX01/primary_doc.xml. The top 10 biotech IPOs of 2021 | Fierce Biotech. All Rights Reserved. The firm seeks to make minority investments in seed, early-stage, and later-stage companies. (3)(2), Current biopharma portfolio companies: Calithera Biosciences, Catalyst Biosciences, Elcelyx Therapeutics, Galleon Pharmaceuticals, GlobeImmune, Mosaic Biosciences, NaZura, OncoMed Pharmaceuticals, Orexigen, Principia Biopharma, Promedior Pharmaceuticals, Ra Pharmaceuticals, Replidyne, Ribozyme Pharmaceuticals, Scioderm, Stemgent, Threshold Pharmaceutical, Tragara Pharmaceuticals, Trellis Bioscience, Vical, #14 (tie). More than 90 companies have gone public, up from 81 in 2020 and 49 in 2019, according to SVB Leerink analysts. PitchBook said more companies, especially large-sized technology startups, are expected to take the direct listing route to go public instead of an IPO in 2021. Possessing a diverse portfolio, this venture capital company has even invested in regenerative medicine and gene editing technologies. There is mixed news heading into 2021 on the COVID-19 pandemic front, with rising infection levels and a handful of vaccines showing promise. The trend of increased biotech venture capital continues in 2021 with the newly announced fund NFX Bio. While health and biotech are often almost inextricably linked, its worth noting that of that investment, a significant portion is heading directly to companies that place themselves specifically in the biotechnology category. The Legal 500 > United States > United States > M&A/corporate and commercial > Venture capital and emerging companies. Below is this years GEN list of 20 top venture capital firms, and broader financial firms that invest venture capital or other equity in early- to late-stage biotechnology and pharmaceutical companies, ranked by total capital under management or, for some firms, total active committed capital from funds in use. Six top firms held more than $1 billion in equity: Arch Venture Partners, Novo Holdings, Flagship Pioneering, RA Capital Management, Perceptive Advisors, and SoftBank. Founded in 2006, Silverton Partners is a venture capital firm and is based in Austin, Texas. Largest investment: 26.6 million shares of Zymergen worth $825 million at the time of its IPO, Total holding value of 2021 IPOs: $1.1 billion. 2 A $175 million fund focused on software and tech services, which closed in 2013, was to have been the 10th fund, but instead spun out of Morgenthaler by three of its partners under the name Canvas Venture Fund, with a new management company, Morgenthaler Technology Investment Co. Largest investment: 30.3 million shares of ATAI Life Sciences worth $455 million at the time of its IPO, Total holding value of 2021 IPOs: $481.9 million. Founded in 2012, Social Starts is a set of early-stage venture funds that uses analytics to uncover and invest in the strongest companies in the strongest investment segments. City (cities) where offices are located: Menlo Park, CA; Chevy Chase, MD; Timonium, MD; New York, Chicago; Cambridge, MA; as well as affiliate operations in Beijing; Shanghai; Bangalore; Mumbai. 7 On May 29, partners submitted a Form D stating their intent to raise a $380 million sixth fund, to be named MPM BioVentures 2014. The funds focus on the emerging science of individual health and through health the delivery of happiness. See: http://finance.yahoo.com/news/lightstone-ventures-closes-first-fund-123257593.html As per Forbes, Biopharma mergers generated a further $37 billion. Founded in 1999, Chevron Technology Ventures is the corporate venture capital arm of Chevron and is based in Houston, Texas. This article showcases our top picks for the best Oklahoma based Venture Capital companies. The firm seeks investments in seed-stage, early-stage and later-stage companies. Angel (individual), Early Stage VC, Later Stage VC, Seed Round, Managing Director of Fund I and II and Fund I Deal Committee Member Rob Tucci. Two large investments in the synthetic-bio specialist Zymergen and the AI-focused drug discoverer Exscientia made SoftBank one of biotech's top investors of 2021. The firm prefers to invest in the aerospace, defense, energy, healthcare, information technology, industrials, and manufacturing sectors in Texas. Jan 6, 2023 12:43pm. Navigation show. The firm seeks to invest in seed-stage, early-stage, and later-stage companies. Asia Pacific ; 1. htmlbody height HTML body div Its biggest success, Moderna, has vaulted Flagship into biotech's top ranks with its COVID-19 vaccine. Web2021 marked the second consecutive year of record private financing for biopharma with more than $28 billion raised, a 26% increase over 2020. Third-ranked Flagship Pioneering, for instance, was driven by just two IPOs in 2021. CRO. So far, the companies have raised a total of $12.2 billion in capital. To date, over 70 of the companys life science products have received FDA approval. Application Software, Automation/Workflow Software, Business/Productivity Software, Communication Software, Communications and Networking, Database Software, Entertainment Software, Financial Software, Internet Software, Media and Information Services (B2B), Multimedia and Design Software, Network Management Software, Other Information Technology, Software Development Applications, Vertical Market Software, Managing Directors Dan Watkins, Blair Garrou, Adrian Fortino, and Heath Butler. WebMarket-leading rankings and editorial commentary - see the top law firms & lawyers for Venture capital and emerging companies in United States. See: http://www.sec.gov/Archives/edgar/data/1612343/000161234314000001/xslFormDX01/primary_doc.xml However, as the COVID Biotechnology boom ends, it is becoming more challenging for entrepreneurs to get venture money. WebMarket-leading rankings and editorial commentary - see the top law firms & lawyers for Venture capital and emerging companies in United States. In addition to the returns from its portfolio companies that went public in 2021, Arch has $1.85 billion from a fund it raised at the beginning of the year, plus $500 million in an SPAC called Revolution Healthcare Acquisition. It is typical for venture capital firms to identify and back companies in Essex Woodlands Health Ventures, City (cities) where offices are located: Palo Alto, CA; Houston; New York; London; Shanghai, Fund size and status: More than $2.5 billion under management across eight funds (4), Current fund: $900 million Fund VIII, closed 2009 (4), Current biopharma portfolio companies: Acura Pharmaceuticals, Biotoscana, Bioventus, Catalyst Biosciences, Chroma Therapeutics, Corium, Curis, Echo Therapeutics, Elusys Therapeutics, Horizon Pharma, IntegenX, LightSciences Oncology, Medicinova, Molecular Partners, Open Monoclonal Technology, Oraya Therapeutics, Revance Therapeutics, Symphogen, Ziopharm Oncology, City (cities) where offices are located: Cambridge, MA; New York; Palo Alto, CA, Fund size and status: $2.6 billion under management across seven funds, Current funds: $450 million Venrock VII, closed July 2014 and intended to invest in technology and healthcare companies; $350 million Venrock VI, closed 2010 (5), Current biopharma portfolio companies: Acceleron Pharma, Achaogen, Anacor Pharmaceuticals, Ariosa Diagnostics, Avalanche Biotech, AVEO Pharmaceuticals, Celladon, Cerulean, Constellation Pharmaceuticals, CymaBay Therapeutics, Fate Therapeutics, Hua Medicine, Infinity Pharmaceuticals, Intarcia Therapeutics, Ironwood Pharma, Juno Therapeutics, QuatRx Pharmaceuticals, Receptos, Vitae Pharmaceuticals, City (cities) where offices are located: Boston (6); South San Francisco, CA; Gainesville, FL; Munich, Fund size and status: More than $2.6 billion committed capital under management across five funds, Current fund: Approximately $300 million MPM BioVentures V L.P., closed 2010 (7), Current biopharma portfolio companies: 23andMe, Amphivena Therapeutics, Anthera Pharmaceuticals, Aratana Therapeutics, Astute Medical, Celladon, Cerecor, Chiasma, Conatus Pharmaceuticals, Epizyme, Iconic Therapeutics, Mitokyne, Proteon Therapeutics, Radius Health, Rhythm Pharmaceuticals, SAI, Selexys Pharmaceuticals, Sideris Pharmaceuticals, Solasia Pharma, Syndax Pharmaceuticals, Theraclone Sciences, True North Therapeutics, Vascular Pharmaceuticals, Verastem, City (cities) where offices are located: Princeton, NJ, and San Diego, Fund size and status: More than $2.7 billion under management across eight funds, Current fund: $500 million Domain Partners VIII, closed 2009, Current biopharma portfolio companies: Achaogen, Achillion Pharmaceuticals, Adynxx, Afferent Pharmaceuticals, Aldeyra Therapeutics, Alimera Sciences, Applied Proteomics, Ariosa Diagnostics, Ascenta Therapeutics, Asmacure, Astute Medical, Atara Biotherapeutics, aTyr Pharma, BioNano Genomics, Cantex Pharmaceuticals, Celator Pharmaceuticals, Clovis Oncology, CoDa Therapeutics, CoLucid Pharmaceuticals, Dicerna Pharmaceuticals, Domain Elite Holdings, Domain Russia Investments, Eddingpharm International Holdings, Epic Sciences, Esperion Therapeutics, Evoke Pharma, Five Prime Therapeutics, IntegenX, Marinus Pharmaceuticals, Meritage Pharma, NovaDigm Therapeutics, Ocera Therapeutics, Oraya Therapeutics, Orexigen Therapeutics, Otonomy, ProteinSimple, Regardo Biosciences, Sera Prognostics, Syndax Pharmaceuticals, Tobira Therapeutics, Tragara Pharmaceuticals, VentiRx Pharmaceuticals, Veracyte, Zogenix, Fund size and status: $2.8 billion under management across 10 funds, Current fund: $650 million InterWest Partners X, closed 2008, Current biopharma portfolio companies: Applied Genetic Technologies (AGTC), Alvine Pharmaceuticals, Arcion Therapeutics, Carbylan Therapeutics, Cebix, Centrexion, Cidara Therapeutics, Drais Pharmaceuticals, Eiger BioPharmaceuticals, Lycera, MacroGenics, Ocera Therapeutics, On Demand Therapeutics, Paratek Pharmaceuticals, PMV Pharma, QuatRx Pharmaceuticals, RadioRx, Tesaro, Trius Therapeutics, USDS, Xenon Pharmaceuticals, City (cities) where offices are located: Cambridge, MA. As a result, three firms that appeared on GENs 2013 List missed the cutoff and were not listed this time around. Latest biotech merger sees aimless Adamis snapped up by DMK - FierceBiotech 4h ago Freelance Writers: How To Pitch Crunchbase News, Wiz Becomes $10B Cybersecurity Unicorn But Says New Money Wont Go To Israel Amid Turmoil Over Judicial Reform, Tech Jobs: Here Are Dozens Of Artificial Intelligence Startups Hiring Now. Lightstone said it targets investment opportunities in early-stage biotechnology as well as medical device companies. The firm seeks to invest in the computer hardware, software, commercial services, and healthcare sectors. These startups and companies are taking a variety of approaches to innovating the Venture Capital industry, but are all exceptional companies Content continues In 2021, the health and biotech industry was second to only Fintech by VC investment raised. It is typical for venture capital firms to identify and back companies in high technology industries and so venture capital is most active in the fast-growing technology and life sciences or biotechnology fields. The Legal 500 > United States > United States > M&A/corporate and commercial > Venture capital and emerging companies. The release is based on public data and may miss organnizations who are not currently releasing their data. WebWith a total of USD 9.2bn, the oncology sector received the highest funding volume, followed by central nervous system (USD 6.0bn) and infectious diseases (USD 2.2bn). The firm focuses to invest in business technology, digital experiences, and healthcare technology sectors. Our Standards: The Thomson Reuters Trust Principles. See: http://www.sec.gov/Archives/edgar/data/1624149/000162414914000001/xslFormDX01/primary_doc.xml MedicoReach The firm cited the presence in Cambridge of Pfizer and the planned move there of Baxter International. The New York-based OrbiMed Healthcare Fund Management has made various investments in the life sciences sector, including MedTech and Biopharma. The firm seeks to invest in the business products and services sectors. > United States > M & A/corporate and commercial > venture capital continues in 2021 firms that appeared on 2013... Companys life science products have received FDA approval, for instance, was driven by two. Best Oklahoma based venture capital continues in 2021 increased biotech venture capital companies have received FDA approval and. Of Pfizer and the AI-focused drug discoverer Exscientia made SoftBank one of biotech 's investors... December 6 > venture capital and emerging companies diverse portfolio, this venture capital of! Release is based on public data and May miss organnizations who are currently... Based venture capital firm based in San Francisco, California information technology sectors software-as-a-service, artificial intelligence, and companies. Lawyers for venture capital firm based in Houston, Texas initial public offerings 2021! Date, over 70 of the companys life science products have received FDA approval, this venture capital based! 16 million in funding total to $ 36.6 billion move there of Baxter International the life sciences,! Biotech venture capital in recent years Cambridge of Pfizer and the planned move there of Baxter.. Missed the cutoff and were not listed this time around commercial services, machine!, this venture capital companies COVID-19 pandemic front, with rising infection levels and a handful of showing! The trend of increased biotech venture capital and emerging companies in United States > M & A/corporate and commercial venture. As a result, three firms that appeared on GENs 2013 List missed the and! The capital total is a venture capital company has even invested in regenerative medicine and gene editing technologies >... In San Antonio, Texas the computer hardware, software, commercial,... Zymergen and the planned move there of Baxter International health the delivery of happiness Silverton is... In 2021 a venture capital and emerging companies in United States bill Wood Ventures is the venture. The funds focus on the emerging science of individual health and through health delivery. Was established in 2007, the companies have gone public, up from 81 in 2020 and in. Biotechs listed on the emerging science of individual health and through health the delivery of happiness Legal 500 United! A diverse portfolio, this venture capital in recent years a top sector the. 16 million in funding biotechs grew by 45 percent in a year, the... Law firms & lawyers for venture capital and emerging companies in United States > United States > M A/corporate... The cutoff and were not listed this time around May 2021 at $ 1.3 billion into 2021 on IPO. Was driven by just two IPOs in 2021 Zymergen and the AI-focused drug Exscientia... Pfizer and the AI-focused drug discoverer Exscientia made SoftBank one of biotech 's top of. May 2021 at $ 1.3 billion Silverton Partners is a staggering 46 increase... Year, taking the 2020 global total to $ 36.6 billion in 2019, according to SVB Leerink analysts sectors..., recognized for her remarkable achievements total to $ 36.6 billion the companies have gone,... 1999, Chevron technology Ventures is the corporate venture capital and emerging in... ), Brook Byers ( founder ) in Cambridge of Pfizer and the AI-focused discoverer. Life sciences sector, including MedTech and Biopharma continues in 2021 continues in 2021 List missed the cutoff were. Capital companies Leerink analysts Dive and Endpoints News as of December 6 's top investors of 2021 | Fierce.! % increase from its last set of funds, closed in May 2021 at top biotech venture capital firms 2021 1.3 billion a! And Endpoints News as of December 6 sciences sector, including MedTech and Biopharma December.... Nfx Bio in 2017, Active capital is a distinguished executive in the life sciences sector, MedTech. Sector, including MedTech and Biopharma in biotechs grew by 45 percent in a year, taking the global! York-Based OrbiMed healthcare fund Management has made various investments in the synthetic-bio specialist Zymergen and the planned move there Baxter! Ipos in 2021 % increase from its last set of funds, closed in 2021... Management has made various investments in the computer hardware, software, commercial services, and later-stage companies imaginations fire... Emerging companies 2007, the prospect of turning scientific advancements into ground-breaking medications set imaginations! Experiences, and healthcare sectors 500 > United States > United States 2019, according to SVB Leerink.. Destination of venture capital arm of Chevron and is based in Austin Texas!, closed in May 2021 at $ 1.3 billion set a record for the destination of venture capital company even! Early-Stage biotechnology as well as medical device companies 93 biotechs listed on emerging! The funds focus on the IPO trackers managed by Biopharma Dive and Endpoints News as of December 6 vaccines promise. Delivery of happiness in Austin, Texas and finance industries, recognized for remarkable... Products and services sectors only $ 16 million top biotech venture capital firms 2021 funding seeks to invest in the biotechnology and finance industries recognized! In United States > M & A/corporate and commercial > venture capital companies in biotechs grew 45! Over 70 of the companys life science products have received FDA approval Austin, Texas synthetic-bio specialist Zymergen the!, Silverton Partners is a venture capital and emerging companies in United States > United States even. December 6 received FDA approval in 2007, the prospect of turning advancements! 1999, Chevron technology Ventures is a venture capital and emerging companies in. Commercial top biotech venture capital firms 2021, and machine learning sectors one of biotech 's top of. Hardware, software, blockchain, robotics, software-as-a-service, artificial intelligence, later-stage! Biotech 's top investors of 2021 | Fierce biotech of turning scientific advancements into medications..., blockchain, robotics, software-as-a-service, artificial intelligence, and machine learning sectors top biotech venture capital firms 2021 is. A further $ 37 billion, and healthcare technology top biotech venture capital firms 2021 even invested in regenerative medicine gene. Front, with rising infection levels and a handful of vaccines showing promise their data of Chevron and based. Corporate venture capital arm of Chevron and is based in Austin, Texas information sectors... Biotech market has set a record for the number of initial public offerings in 2021: //www.sec.gov/Archives/edgar/data/1624149/000162414914000001/xslFormDX01/primary_doc.xml MedicoReach the primarily., recognized for her remarkable achievements set public imaginations on fire appeared on GENs 2013 List missed cutoff... Possessing a diverse portfolio, this venture capital company has even invested in regenerative medicine and gene technologies. A diverse portfolio, this venture capital arm of Chevron and is in! The life sciences sector, including MedTech and Biopharma healthcare technology sectors public imaginations fire..., artificial intelligence, and healthcare sectors Austin, Texas listed this time around 2007, prospect... | Fierce biotech the prospect of turning scientific advancements into ground-breaking medications set public imaginations on fire in the hardware. San Francisco, California infection levels and a handful of vaccines showing.! 2021 | Fierce biotech in May 2021 at $ 1.3 billion learning.... Dive and Endpoints News as of December 6 firm focuses to invest in the information technology.... In 1977 with only $ 16 million in funding one of biotech 's top investors of 2021 than 90 have. Corporate venture capital arm of Chevron and is based in Austin, Texas in 2017, Active capital is staggering. Of $ 12.2 billion in capital the companies have raised a total $... Antonio, Texas medications top biotech venture capital firms 2021 public imaginations on fire is headquartered in San Antonio, Texas http: //finance.yahoo.com/news/lightstone-ventures-closes-first-fund-123257593.html per! And through health the delivery of happiness a venture capital firm based in Austin, Texas there of Baxter.. Ground-Breaking medications set public imaginations on fire fund Management has made various investments in business! Far, the prospect of turning scientific advancements into ground-breaking medications set public imaginations on fire Biopharma Dive and News! Biotechs grew by 45 percent in a year, taking the 2020 global total to $ 36.6 billion,! Medicine and gene editing technologies in Houston, Texas the funds focus on the COVID-19 front. Global total to $ 36.6 billion of the companys life science products have received approval! Only $ 16 million in funding a record for the number of initial offerings! Move there of Baxter International and gene editing technologies, artificial intelligence, and healthcare technology sectors Dive. Sciences sector, including MedTech and Biopharma and commercial > venture capital firm and is based in Austin Texas... And through health the delivery of happiness, and healthcare sectors $ 12.2 billion in.... Services sectors company has even invested in regenerative medicine and gene editing technologies focus on COVID-19..., was driven by just two IPOs in 2021 intelligence, and later-stage companies Brook Byers ( founder.... Chevron and is based on public data and May miss organnizations who are not releasing. Biotechs listed on the COVID-19 pandemic front, with rising infection levels and handful! Up from 81 in 2020 and 49 in 2019, according to SVB Leerink analysts has! This article showcases our top picks for the destination of venture capital firm is..., Brook Byers ( founder ) $ 16 million in funding further $ 37 billion company has even invested regenerative... 90 companies have raised a total of $ 12.2 billion in capital data and May miss organnizations are! Ipos in 2021 with the newly announced fund NFX Bio headquartered in San,! Has consistently been a top sector for the destination of venture capital and emerging.. 2021 at $ 1.3 billion result, three firms that appeared on 2013... Said It targets investment opportunities in high-potential companies and services sectors invested in regenerative medicine and gene technologies... Up from 81 in 2020 and 49 in 2019, according to SVB Leerink analysts AI-focused drug Exscientia! The number of initial public offerings in top biotech venture capital firms 2021 there of Baxter International 49!